Can a New Drug Combo Prevent Death by Suicide?
A new study suggests that a combination of ketamine and buprenorphine may significantly reduce suicidal thoughts in patients. Researchers found that nearly 80 percent of participants receiving the drug combination were no longer clinically suicidal after a month. This promising result indicates the need for larger trials to further explore the treatment's potential.
- ▪Suicide rates remain a public health crisis despite a slight decline in recent years.
- ▪A study from Stanford University tested a combination of ketamine and buprenorphine on patients with major depressive disorder and suicidal ideation.
- ▪Results showed that nearly 80 percent of patients receiving buprenorphine were no longer clinically suicidal after one month.
Nautilus files mainly under culture. We currently carry 31 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Nautil |
| Canonical URL | https://nautil.us/can-a-new-drug-combo-prevent-death-by-suicide-1281440/ |
| Publication time | Wed, 27 May 2026 18:00:06 +0000 |
| Retrieval time | 2026-05-27T18:08:02.537Z |
| Last seen | 2026-05-27T18:08:02.537Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | I8jpmhyjSYPl |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"Article","headline":"Can a New Drug Combo Prevent Death by Suicide?","description":"Can a New Drug Combo Prevent Death by Suicide?: It may reduce suicidal intent for up to a month or more","image":["https://lede-admin.nautil.us/wp-content/uploads/sites/70/2026/05/French_hero_5497ac.png"],"datePublished":"2026-05-27T18:00:06+00:00","dateModified":"2026-05-27T18:00:08+00:00","author":[{"@type":"Person","name":"Kristen…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Nautil.
Discussion
0 commentsMore from Nautil
